WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 23-May-2016 (Data received as of 20-May-2016)
Next overall update Fall 2016
2015 data are provisionary
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1'2601 Infant (under 12 months) mortality rate: 652
GDP / capita (US$): 3'8971 Child (under 5 years) mortality rate: 852

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 4'068  3'970  3'873  3'777  3'683  2'711  2'024  1'534 
Births 134  133  131  129  128  104  83  66 
Surviving infants 126  124  122  121  119  96  76  60 
Pop. less than 5 years 601  592  584  575  565  445  350  273 
Pop. less than 15 years 1'628  1'598  1'568  1'536  1'505  1'163  902  696 
Female 15-49 years 984  959  934  909  886  636  461  346 

Number of reported cases

(Click for retrospective incidence data for Mauritania)
Diphtheria
ChartChart
  18 
Japanese encephalitis
ChartChart
 
Measles
ChartChart
  14  62  35  234  1'379  11'441 
Mumps
ChartChart
 
Pertussis
ChartChart
  30  383  7'576 
Polio*
ChartChart
  159 
Rubella
ChartChart
  49  61 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  16 
Tetanus (total)**
ChartChart
  24  12 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Mauritania)
Vaccine year result method % card seen                                                
BCG 2013  97  CES   55  85  98  95  95  86  48  79 
DTP1 2013  96  CES   55  87  88  95  95  91 
DTP3 2013  92  CES   55  73  84  80  80  75  31  33 
DTP4         
IPV1         
HepB_BD          51  49  24 
HepB3 2013  92  CES   55  73  84  80  80  75 
Hib3 2013  92  CES   55  73  84  80  80  75 
JapEnc         
MCV1          70  84  80  75  67  38 
MCV2         
PCV1          85  88  23 
PCV3          71  84  20 
Pol3 2013  91  CES   55  67  84  80  80  73  31  33 
Rota1          73 
RotaC         
Rubella1         
TT2plus 2010  41  MICS   32  37  42  40  40  29  15 
PAB         
VAD1         
YFV 1988  36  EPI   69  32 
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Mauritania)
BCG
ChartChart
  98  95  95  86  78  79 
DTP1
ChartChart
  88  95  95  91  73  69 
DTP3
ChartChart
  84  80  80  75  51  33 
HepB3
ChartChart
  84  80  80  75 
HepB_BD
ChartChart
 
Hib3
ChartChart
  84  80  80  75 
MCV1
ChartChart
  84  80  75  67  46  38 
MCV2
ChartChart
 
PAB
ChartChart
  80  80  80  80  44  24 
PCV3
ChartChart
  84 
Pol3
ChartChart
  84  80  80  73  58  33 
RotaC
ChartChart
 
YFV
ChartChart
 

Number of districts in the country 56  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 18
From 80 to 89% 13
From 50 to 79% 59
Less than 50% 11
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 9-11 years; No From November 2016
HepB birth; Yes
IPV 14 weeks; Yes
Measles 9 months; Yes
OPV Birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
Td 1st contact or pregnancy; +1, +6 months;+1, +1 year; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2015  2012-2015  2012-2015  2012-2015  2008-2012  2008-2012   
Nº of districts with microplans that include activities to raise immunization coverage number 53  53  53  39  39     

System performance

Total Nº districts in country number 53  53  53  53  53  53  53 
Nº districts with DTP3 coverage >=80% number 30  22  21  15  12 
% of districts with DTP3 coverage >=80% From 0 to 100% 57  42  40  28  17  11  23 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 15 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  No  No  No  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  No  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 41  46  340     

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  No  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.